0.1% Dexamethasone

DRUG3 trials

Sponsors

Sun Pharmaceutical Industries Limited, Wannisa Suphachearabhan

Conditions

BlepharoconjunctivitisRecurrent Pterygium of EyeSteroid-Induced Glaucoma

Phase 3

Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

CompletedNCT00578955

Sun Pharmaceutical Industries LimitedBlepharoconjunctivitis

Start: 2007-12-31End: 2008-10-31Updated: 2021-11-19

Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

WithdrawnNCT00754949

Sun Pharmaceutical Industries LimitedBlepharoconjunctivitis

Updated: 2021-11-22

Phase 4

Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium

CompletedNCT04075227

Wannisa SuphachearabhanRecurrent Pterygium of Eye, Steroid-Induced Glaucoma

Start: 2015-10-16End: 2019-03-02Updated: 2019-09-06